Qube Research & Technologies LTD Bio Xcel Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$2.32 - $5.51 $34,333 - $81,542	14,799 Added 201.29%	22,151 $65,000
Q3 2023 Nov 13, 2023	BUY	$2.49 - $11.85 $18,306 - $87,121	7,352 New	7,352 $18,000
Q4 2021 Feb 01, 2022	SELL	$20.12 - $35.09 $250,413 - $436,730	-12,446 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$23.84 - $32.03 $29,752 - $39,973	1,248 Added 11.14%	12,446 $378,000
Q2 2021 Aug 13, 2021	SELL	$29.06 - $38.83 $16,477 - $22,016	-567 Reduced 4.82%	11,198 $325,000
Q1 2021 May 14, 2021	SELL	$39.04 - $64.6 $724,387 - $1.2 Million	-18,555 Reduced 61.2%	11,765 $508,000
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $1.29 Million - $1.72 Million	30,320 New	30,320 $1.4 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.